Companies: 48,687 Total Market Cap: 125809765390872.04

Novo Nordisk A/S

NYSE: NVO
Healthcare Drug Manufacturers - General
Rank #31
Market Cap 298.09 B
Volume 16.44 M
Price 65.60
Change (%) 1.28%
Country or region United States United States

Novo Nordisk A/S's latest marketcap:

298.09 B

As of May 2, 2025, Novo Nordisk A/S's market capitalization has reached $298.09 B. According to our data, Novo Nordisk A/S is the 31th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 298.09 B
Revenue (ttm) 40.31 B
Net Income (ttm) 14.02 B
Shares Out 4.44 B
EPS (ttm) 3.14
Forward PE 16.22
Ex-Dividend Date March 31, 2025
Earnings Date May 7, 2025
Market Cap Chart
Data Updated: May 2, 2025

Novo Nordisk A/S's yearly market capitalization.

Novo Nordisk A/S has seen its market value grow from $6.00 B to $277.19 B since 1998, representing a total increase of 4,521.10% and an annual compound growth rate (CAGR) of 15.68%.
Date Market Cap Change (%)
April 25, 2025 $277.19 B -28.55%
December 31, 2024 $387.95 B -17.76%
December 29, 2023 $471.73 B 54.12%
December 30, 2022 $306.08 B 19.24%
December 31, 2021 $256.69 B 55.86%
December 31, 2020 $164.70 B 16.14%
December 31, 2019 $141.81 B 23.12%
December 31, 2018 $115.18 B -15.84%
December 29, 2017 $136.86 B 46.79%
December 30, 2016 $93.24 B -38.18%
December 31, 2015 $150.82 B 29.59%
December 31, 2014 $116.38 B 12.48%
December 31, 2013 $103.47 B 9.3%
December 31, 2012 $94.66 B 36.88%
December 30, 2011 $69.16 B -0.91%
December 31, 2010 $69.79 B 72.41%
December 31, 2009 $40.48 B 26.82%
December 31, 2008 $31.92 B -22.43%
December 31, 2007 $41.15 B 52.03%
December 29, 2006 $27.07 B 44.82%
December 30, 2005 $18.69 B 1.87%
December 31, 2004 $18.35 B 29.73%
December 31, 2003 $14.14 B 41.73%
December 31, 2002 $9.98 B 9.16%
December 28, 2001 $9.14 B 14.52%
December 29, 2000 $7.98 B 36.89%
December 31, 1999 $5.83 B -2.78%
December 31, 1998 $6.00 B

Company Profile

About Novo Nordisk A/S

Novo Nordisk A/S, together with its subsidiaries, is a global pharmaceutical company specializing in research, development, manufacturing, and distribution. Headquartered in Bagsvaerd, Denmark, the company operates across Europe, the Middle East, Africa, North America, and Asia, including Mainland China, Hong Kong, and Taiwan.

Business Segments

  • Diabetes and Obesity Care: Offers products for diabetes, obesity, cardiovascular diseases, and other emerging therapies.
  • Rare Disease: Provides treatments for rare blood disorders, rare endocrine disorders, and hormone replacement therapy.

Key Products & Innovations

  • Insulin pens, growth hormone pens, and injection needles.
  • Smart diabetes solutions, including smart insulin pens and the Dose Check app for insulin dose guidance.

Strategic Collaborations

  • Partnership with UNICEF to address childhood obesity.
  • Collaboration with Valo Health, Inc. to develop novel cardiometabolic treatments.

Founded in 1923, Novo Nordisk A/S continues to be a leader in pharmaceutical innovation.

Frequently Asked Questions

As of May 2, 2025, Novo Nordisk A/S (including the parent company, if applicable) has an estimated market capitalization of $298.09 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Novo Nordisk A/S global market capitalization ranking is approximately 31 as of May 2, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region United States
Founded 1923
IPO Date n/a
Employees n/a
CEO Lars Jorgensen
Sector Healthcare
Industry Drug Manufacturers - General
Address Novo Alle 1
Bagsvaerd, 2880
Denmark
People Also Watch
LLY
794.10 1.28%
JNJ
154.46 1.28%
ABBV
193.34 1.28%
SWX-ROG
329.53 1.28%